French Presidential Race CentreRight Candidate Edouard Philippe Emerges as Early Favorite to Counter Populist Rivals Argus Research Highlights LongTerm Growth Potential for Applied Materials AMAT Iran Never Bow Vow and Trump Counteroffer Rejection Intensify Middle East Tensions Raising Oil Supply Risks Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Anthropic Overtakes OpenAI as Most Valuable AI Startup with 65 Billion Funding Round Retail Hiring Surge Masks Consumer Caution April Jobs Data Sparks Concerns BBLG Q1 2026 Earnings Narrowed Loss Beats Estimates as Bone Biologics Advances Pipeline XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges Citi Trends Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Stock Surges Santacruz Silver Mining SCZM Q1 2026 Earnings EPS Misses Estimates as Stock Declines HEI Q4 2025 Earnings EPS Surprise Beats Estimates Despite Tepid Market Response Mister Car Wash MCW Q1 2026 Earnings EPS Surprise Beats Estimates Amid Steady Operations Cato Corporation CATO Edges Higher Amid Modest Volume Key Levels in Focus First Financial Bankshares FFIN Experiences Slight Pullback Amid Steady Trading Element Solutions Inc ESI Holds Near Support as Modest Decline Suggests Consolidation Phase Hub Group Inc HUBG Edges Higher as Logistics Sector Shows Resilience Viatris VTRS Under Pressure Support Levels Tested After 15 Decline Roivant Shares Surge as Company Reports Swing to Profitability Potential SpaceX IPO Could Join Historys Largest Stock Market Debuts AEW Double or Nothing 2026 Match Card Streaming Details and Event Strategy for May 24 PayPerView April Jobs Report Preview Labor Market Cooling but Resilient Economists Anticipate Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office Elon Musk and Sam Altmans Rivalry Intensifies on Wall Street Australia Files Record 2bn Lawsuit Against 3M Over PFAS Contamination at Defence Sites SLMBP Q1 2026 Earnings Strong EPS Surprise of 356 Amid Stable Performance Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes